Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OCTREOTIDE vs ODEVIXIBAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OCTREOTIDE vs ODEVIXIBAT: Safety Overview

Metric OCTREOTIDE ODEVIXIBAT
Total FAERS Reports 23,724 223
Deaths Reported 5,003 10
Death Rate 21.1% 4.5%
Hospitalizations 7,779 43
Average Patient Age 61.8 yrs 14.3 yrs
% Female Patients 55.2% 49.4%
FDA Approval Date Apr 8, 2005 Jul 20, 2021
Manufacturer Mylan Institutional LLC Albireo Pharma, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription